NYSE MKT
SENS

Senseonics Holdings Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Senseonics Holdings Inc Stock Price

Vitals

Today's Low:
$0.5865
Today's High:
$0.6344
Open Price:
$0.6059
52W Low:
$0.5
52W High:
$1.63
Prev. Close:
$0.622
Volume:
3017739

Company Statistics

Market Cap.:
$306.58 million
Book Value:
0.107
Revenue TTM:
$18.46 million
Operating Margin TTM:
-411.83%
Gross Profit TTM:
$2.73 million
Profit Margin:
0%
Return on Assets TTM:
-28.91%
Return on Equity TTM:
-128.01%

Company Profile

Senseonics Holdings Inc had its IPO on 2016-03-17 under the ticker symbol SENS.

The company operates in the Healthcare sector and Medical Devices industry. Senseonics Holdings Inc has a staff strength of 121 employees.

Stock update

Shares of Senseonics Holdings Inc opened at $0.61 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.59 - $0.63, and closed at $0.62.

This is a +0.29% increase from the previous day's closing price.

A total volume of 3,017,739 shares were traded at the close of the day’s session.

In the last one week, shares of Senseonics Holdings Inc have increased by +10.6%.

Senseonics Holdings Inc's Key Ratios

Senseonics Holdings Inc has a market cap of $306.58 million, indicating a price to book ratio of 12.4452 and a price to sales ratio of 36.4515.

In the last 12-months Senseonics Holdings Inc’s revenue was $18.46 million with a gross profit of $2.73 million and an EBITDA of $-75089000. The EBITDA ratio measures Senseonics Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Senseonics Holdings Inc’s operating margin was -411.83% while its return on assets stood at -28.91% with a return of equity of -128.01%.

In Q2, Senseonics Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 11.1%.

Senseonics Holdings Inc’s PE and PEG Ratio

Forward PE
21.5054
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.17 per share while it has a forward price to earnings multiple of 21.5054 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Senseonics Holdings Inc’s profitability.

Senseonics Holdings Inc stock is trading at a EV to sales ratio of 33.5919 and a EV to EBITDA ratio of 2.1261. Its price to sales ratio in the trailing 12-months stood at 36.4515.

Senseonics Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$153.36 million
Total Liabilities
$15.86 million
Operating Cash Flow
$-4076000.00
Capital Expenditure
$0
Dividend Payout Ratio
0%

Senseonics Holdings Inc ended 2024 with $153.36 million in total assets and $0 in total liabilities. Its intangible assets were valued at $153.36 million while shareholder equity stood at $52.54 million.

Senseonics Holdings Inc ended 2024 with $1.79 million in deferred long-term liabilities, $15.86 million in other current liabilities, 493000.00 in common stock, $-827965000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $28.55 million and cash and short-term investments were $117.62 million. The company’s total short-term debt was $483,000 while long-term debt stood at $39.11 million.

Senseonics Holdings Inc’s total current assets stands at $138.23 million while long-term investments were $7.45 million and short-term investments were $89.07 million. Its net receivables were $5.71 million compared to accounts payable of $975000.00 and inventory worth $9.19 million.

In 2024, Senseonics Holdings Inc's operating cash flow was $-4076000.00 while its capital expenditure stood at $0.

Comparatively, Senseonics Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.62
52-Week High
$1.63
52-Week Low
$0.5
Analyst Target Price
$1.67

Senseonics Holdings Inc stock is currently trading at $0.62 per share. It touched a 52-week high of $1.63 and a 52-week low of $1.63. Analysts tracking the stock have a 12-month average target price of $1.67.

Its 50-day moving average was $0.73 and 200-day moving average was $0.85 The short ratio stood at 8.27 indicating a short percent outstanding of 0%.

Around 726% of the company’s stock are held by insiders while 2404% are held by institutions.

Frequently Asked Questions About Senseonics Holdings Inc

The stock symbol (also called stock or share ticker) of Senseonics Holdings Inc is SENS

The IPO of Senseonics Holdings Inc took place on 2016-03-17

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$29.9
-1.56
-4.96%
$0.07
0.04
+146.67%
$70.31
0.28
+0.4%
$3.59
-0.11
-2.97%
$9.78
-0.15
-1.51%
$0.51
0.05
+11.11%
Arvind Limited (ARVIND)
$158.95
-12.9
-7.51%
NetApp Inc (NTAP)
$78.32
-0.21
-0.27%
$52.82
-1.07
-1.99%
$159.95
-6.15
-3.7%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Address

20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005